TITLE

Fresenius: warning will not affect earnings

PUB. DATE
March 2013
SOURCE
Medical Device Daily;3/27/2013, Vol. 17 Issue 59, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article reports on the impact of the March 5, 2013 warning letter received by Fresenius North America from the U.S. Food and Drug Administration (FDA) on the company's guidance in terms of revenue and earnings in 2013.
ACCESSION #
86441655

 

Related Articles

  • FDA probing dialysis patients' deaths.  // Plastics News;9/16/2002, Vol. 14 Issue 29, p31 

    Reports the investigation of the U.S. Food and Drug Administration on the possible influence of tubing used in dialysis equipments on the death of dialysis patients.

  • FDA scrutiny adds to woes at Akorn specialty drug firm. Murphy, H. Lee // Crain's Chicago Business;11/06/2000, Vol. 23 Issue 46, p26 

    Reports that the United States Food and Drug Administration has cited Akorn Inc. for failing to comply with quality control rules at its Decatur plant. Failure of products to meet established quality standards; Decline of the stock price of the company.

  • validation master plan. Albert, Bruce // Global Cosmetic Industry;May2002, Vol. 170 Issue 5, p46 

    Assesses the marketing strategies of cosmetic companies in the U.S. Impact of the Food and Drug Administration regulations on manufacturers; Elements of a validation program; Description on the function of quality control and microbiology .

  • Modernizing Pharmaceutical Manufacturing. Wechsler, Jill // Pharmaceutical Technology North America;Feb2002, Vol. 26 Issue 2, p16 

    Focuses on the application of modern process analytical technology to pharmaceutical production and quality control in the U.S. Goal of Federal and Drug Administration to reduce product quality problems; Efficiency of manufacturing and quality assurance processes; Feasibility of parametric...

  • We All Need Quality Systems, Even at me Cellular Level. Bush, Laura // BioPharm International;Nov2006, Vol. 19 Issue 11, p12 

    The article reflects on the need for a quality system for nanotechnology. The author stresses that the system describes a holistic way of looking at quality and addresses a key aspect of quality control in more detail. He stresses the need for the U.S. Food and Drug Administration to develop a...

  • Laying the groundwork for HACCP. O'Donnell, Claudia D. // Prepared Foods;Apr94, Vol. 163 Issue 4, p49 

    Focuses on the hazard analysis and critical control points (HACCP), an acronym for preventive quality control system should be required for a number of food products. Proposal of the US Food and Drug Administration to make HACCP mandatory for the seafood industry; Issues to be settled;...

  • CorTechs said to have missed quality audits.  // Medical Device Daily;10/13/2010, Vol. 14 Issue 199, p8 

    The article reports on the September 1, 2010 warning letter of the U.S. Food and Drug Administration (FDA) to CorTechs Labs indicating that the company failed to perform the required quality audit of the FDA.

  • FDA Implements ICH Q8 and Q9, and Withdraws Old Guidances. Holland-Moritz, Pam // BioPharm International;Jul2006, Vol. 19 Issue 7, p16 

    The article reports on the implementation of new guidelines issued by the U.S. Food and Drug Administration to streamline cost and reduce regulatory intervention of pharmaceutical and biotechnology manufacturing processes. The agency issued an International Conference on Harmonization guidance...

  • Med-Tech Notes.  // Medical Device Daily;10/2/2013, Vol. 17 Issue 190, p3 

    This section offers news briefs in the medical technology industry as of October 2, 2013. Integra LifeSciences Holdings has announced that it was informed by the U.S. Food and Drug Administration (FDA) that it had addressed the violations in the warning letter relating to its Plainsboro, New...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics